ClearPoint Neuro/CLPT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ClearPoint Neuro

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Ticker

CLPT

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

Headquarters

Solana beach, United States

Employees

107

ClearPoint Neuro Metrics

BasicAdvanced
$149M
Market cap
-
P/E ratio
-$0.83
EPS
1.05
Beta
-
Dividend rate
$149M
1.05
$8.37
$4.05
3.2
3.138
2.613
28.811
-39.71%
-61.42%
-49.90%
5.691
4.305
4.419
24.86%
-12.39%
23.14%

What the Analysts think about ClearPoint Neuro

Analyst Ratings

Majority rating from 3 analysts.
Buy

ClearPoint Neuro Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-53.94% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$7.6M
11.76%
Net income
-$4.1M
-10.87%
Profit margin
-53.94%
-20.25%

ClearPoint Neuro Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.79%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.29
-$0.20
-$0.19
-$0.16
-
Expected
-$0.19
-$0.25
-$0.20
-$0.19
-$0.18
Surprise
52.63%
-20.00%
-6.56%
-15.79%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ClearPoint Neuro stock?

ClearPoint Neuro (CLPT) has a market cap of $149M as of June 22, 2024.

What is the P/E ratio for ClearPoint Neuro stock?

The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of June 22, 2024.

Does ClearPoint Neuro stock pay dividends?

No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of June 22, 2024.

When is the next ClearPoint Neuro dividend payment date?

ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.

What is the beta indicator for ClearPoint Neuro?

ClearPoint Neuro (CLPT) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the ClearPoint Neuro stock price target?

The target price for ClearPoint Neuro (CLPT) stock is $10, which is NaN% below the current price of $. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ClearPoint Neuro stock

Buy or sell ClearPoint Neuro stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing